Skip to main navigation Skip to search Skip to main content

BREATHE – B cell Receptor Evaluation for Antibodies to protect Human Exposure to SARS-CoV-2

Project Details

Short titleBREATHE – B cell Receptor Evaluation for Antibodies to protect Human Exposure to SARS-CoV-2
StatusFinished
Effective start/end date1/07/20 → 30/06/21

Funding

  • Alchemab Therapeutics Ltd